Impact Biomedical Inc. Signs Material Definitive Agreement
Ticker: IBO · Form: 8-K · Filed: Jul 28, 2025 · CIK: 1834105
| Field | Detail |
|---|---|
| Company | Impact Biomedical Inc. (IBO) |
| Form Type | 8-K |
| Filed Date | Jul 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
TL;DR
Impact Biomedical Inc. just signed a big deal, filing an 8-K on 7/28/25 for an agreement dated 7/21/25.
AI Summary
Impact Biomedical Inc. entered into a material definitive agreement on July 21, 2025. The company, incorporated in Nevada with its principal executive offices in Houston, TX, filed this 8-K report on July 28, 2025, detailing this significant event. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates a significant new contract or partnership for Impact Biomedical Inc., which could impact its future revenue and operations.
Risk Assessment
Risk Level: medium — The nature of the material definitive agreement is not specified, leaving its potential impact and risks unknown.
Key Numbers
- 001-42212 — Commission File Number (Identifier for Impact Biomedical Inc.)
- 85-3926944 — IRS Employer Identification No. (Tax identification for Impact Biomedical Inc.)
Key Players & Entities
- Impact Biomedical Inc. (company) — Registrant
- July 21, 2025 (date) — Date of earliest event reported
- July 28, 2025 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- Houston, TX (location) — Address of principal executive offices
- 001-42212 (identifier) — Commission File Number
- 85-3926944 (identifier) — IRS Employer Identification No.
FAQ
What is the nature of the material definitive agreement entered into by Impact Biomedical Inc. on July 21, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into on July 21, 2025.
When was this Form 8-K filed with the SEC?
This Form 8-K was filed on July 28, 2025.
In which state is Impact Biomedical Inc. incorporated?
Impact Biomedical Inc. is incorporated in Nevada.
What is the principal executive office address for Impact Biomedical Inc.?
The principal executive offices are located at 1400 Broadfield Blvd., Suite 130, Houston, TX 77084.
What are the key items reported in this 8-K filing?
The key items reported are the entry into a material definitive agreement and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding IMPACT BIOMEDICAL INC. (IBO).